Annie J. Kruger

546 total citations
20 papers, 422 citations indexed

About

Annie J. Kruger is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Annie J. Kruger has authored 20 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Genetics and 7 papers in Immunology. Recurrent topics in Annie J. Kruger's work include Diabetes and associated disorders (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (4 papers). Annie J. Kruger is often cited by papers focused on Diabetes and associated disorders (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (4 papers). Annie J. Kruger collaborates with scholars based in United States, Australia and France. Annie J. Kruger's co-authors include Rita Bortell, Nadia Alatrakchi, Raymond T. Chung, Shadi Salloum, Jacinta A. Holmes, Dale L. Greiner, Aldo A. Rossini, Esperance Schaefer, Kathleen E. Corey and Wenyu Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Annie J. Kruger

16 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annie J. Kruger United States	12	181	117	89	78	75	20	422
Richard J. Milton United States	7	301 1.7×	206 1.8×	155 1.7×	50 0.6×	115 1.5×	7	527
G. Marquitan Germany	10	207 1.1×	122 1.0×	132 1.5×	27 0.3×	38 0.5×	12	386
José M. Ramos Pittol Netherlands	11	127 0.7×	75 0.6×	173 1.9×	181 2.3×	122 1.6×	19	415
Chihiro Kawai Japan	7	175 1.0×	125 1.1×	103 1.2×	15 0.2×	67 0.9×	22	391
Kim Olievier Belgium	8	134 0.7×	91 0.8×	118 1.3×	22 0.3×	45 0.6×	10	358
Qinyu Xu China	5	252 1.4×	109 0.9×	141 1.6×	15 0.2×	60 0.8×	9	418
Tetsuharu Oriishi Japan	10	155 0.9×	98 0.8×	63 0.7×	65 0.8×	89 1.2×	21	357
Chunpan Zhang China	12	133 0.7×	89 0.8×	91 1.0×	47 0.6×	49 0.7×	26	397
Brian Ko United States	8	139 0.8×	90 0.8×	188 2.1×	118 1.5×	180 2.4×	13	483
Hovsep Mahdessian Sweden	8	244 1.3×	57 0.5×	86 1.0×	20 0.3×	92 1.2×	13	424

Countries citing papers authored by Annie J. Kruger

Since Specialization

Citations

This map shows the geographic impact of Annie J. Kruger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie J. Kruger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie J. Kruger more than expected).

Fields of papers citing papers by Annie J. Kruger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie J. Kruger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie J. Kruger. The network helps show where Annie J. Kruger may publish in the future.

Co-authorship network of co-authors of Annie J. Kruger

This figure shows the co-authorship network connecting the top 25 collaborators of Annie J. Kruger. A scholar is included among the top collaborators of Annie J. Kruger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie J. Kruger. Annie J. Kruger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Badalamenti, Salvatore, Annie J. Kruger, Robert J. Pomponio, et al.. (2025). A Randomized Phase I Trial Evaluating Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eclitasertib, a RIPK1 Inhibitor, in Healthy Participants. Advances in Therapy. 42(8). 3993–4012. 1 indexed citations

Kruger, Annie J., Andrew W. Roberts, Yong Lin, et al.. (2025). Biologic Switch Timing and Risk of Infection in Patients With Ulcerative Colitis/Crohn’s Disease: A Retrospective Study. Clinical Gastroenterology and Hepatology. 23(12). 2253–2262.

Xiang, Junhuai, Hillol Sarker, Bozhao Qi, et al.. (2025). Endoscopic Scoring and Localization in Unconstrained Clinical Trial Videos. 4006–4015.

Badalamenti, Salvatore, Wei Zhao, Roger Trullo, et al.. (2024). P487 Automated Scoring of Patient Endoscopy Videos Using Deep Learning Techniques: A Promising Approach for Clinical Trials in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 18(Supplement_1). i968–i968.

Altınbaş, Akif, Jacinta A. Holmes, Shadi Salloum, et al.. (2022). LOXL-2 and TNC-C Are Markers of Liver Fibrogenesis in HCV/HIV-, HIV- and HCV-Infected Patients. Biomarkers in Medicine. 16(11). 839–846. 2 indexed citations

Davis, William D., et al.. (2022). Chronic Lymphocytic Leukemia Involving the Liver Without High-Grade Transformation. SHILAP Revista de lepidopterología. 1(7). 2 indexed citations

Salloum, Shadi, Annie J. Kruger, Jacinta A. Holmes, et al.. (2021). Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1297–1310. 37 indexed citations

Nadella, Sandeep, Hong Cao, Narayan Shivapurkar, et al.. (2019). A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. Digestive Diseases and Sciences. 65(1). 189–203. 16 indexed citations

Kim, Mi-Young, Annie J. Kruger, Ju‐Yeon Jeong, et al.. (2019). Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells. Molecules and Cells. 42(6). 448–459. 30 indexed citations

10.

Holmes, Jacinta A., Eoin R. Feeney, Annie J. Kruger, et al.. (2018). Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. 218(9). 1394–1403. 36 indexed citations

11.

Kruger, Annie J., Bryan C. Fuchs, Ricard Masia, et al.. (2018). Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis. Hepatology Communications. 2(5). 529–545. 50 indexed citations

12.

Salloum, Shadi, Jacinta A. Holmes, Rohit Jindal, et al.. (2016). Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology. 64(6). 1951–1968. 35 indexed citations

13.

Brisac, Cynthia, Shadi Salloum, Esperance Schaefer, et al.. (2016). IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway. Journal of Hepatology. 65(5). 972–979. 19 indexed citations

14.

Mueller, Jessica L., Eoin R. Feeney, Hui Zheng, et al.. (2015). Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology. 6(10). e114–e114. 40 indexed citations

15.

Kruger, Annie J., Sudipta Tripathi, Bing Zhu, et al.. (2014). Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes. PLoS ONE. 9(2). e89561–e89561. 53 indexed citations

16.

Kruger, Annie J., et al.. (2010). The role of innate immune pathways in type 1 diabetes pathogenesis. Current Opinion in Endocrinology Diabetes and Obesity. 17(2). 126–130. 40 indexed citations

17.

Kruger, Annie J., Chaoxing Yang, Kathryn L. Lipson, et al.. (2010). Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats. Autoimmunity. 44(2). 137–148. 30 indexed citations

18.

Kruger, Annie J., Chaoxing Yang, Sun W. Tam, et al.. (2010). Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats. Experimental Biology and Medicine. 235(11). 1328–1337. 20 indexed citations

19.

Miller, David M., Thomas B. Thornley, Todd Pearson, et al.. (2009). TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade,. The Journal of Immunology. 182(9). 5547–5559. 11 indexed citations

20.

Kruger, Annie J.. (2009). Grundlagen der Metastasierung von Tumorzellen: systembiologische Aspekte. TumorDiagnostik & Therapie. 30(2). 71–73.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact